T&W Medical

What T&W Medical does

T&W Medical A/S is a privately held Danish family-owned holding and investment company headquartered in Lynge, Denmark, equally owned (50/50) by the Tøpholm and Westermann families across four generations of family involvement. The company's stated purpose is to own and invest in high-technology companies within medtech and life science, serving patients and healthcare systems focused on hearing impairment, epilepsy, neurological monitoring, and adjacent medical challenges.

The company's operating footprint centers on WS Audiology (WSA), a majority-owned (51%) global hearing-aid manufacturer operating the Widex and Signia brands, formed through the 2019 merger of Widex A/S with EQT-owned Sivantos following European Commission approval. WS Audiology generates substantially all consolidated revenue (DKK 19.25 billion in FY2024/25) by developing, manufacturing, and distributing hearing aids through wholly-owned sales companies and independent distributors across approximately 130 markets, with R&D centers in Denmark, Germany, and Singapore and a workforce of around 12,000. Adjacent medtech holdings include UNEEG medical (CE-marked subcutaneous EEG monitoring for epilepsy) and Cebreo Medical (discrete long-term EEG monitoring with multi-sensor integration for neurological disorders). R&D investment across the group is sustained at approximately 7% of revenue (DKK 1.39 billion in FY2024/25).

The business model is a multi-asset holding structure. Medtech holdings generate revenue primarily through hardware sales of medical devices to healthcare providers and end consumers via B2B2C channels. A seed-and-venture portfolio invests in earlier-stage medtech and life-science companies (Cortrium, Eyenuk, Human Bytes, Biolinq, O2matic, CelVivo, Optheras) operating across AI diagnostics, biosensing, oxygen therapy, 3D cell models, and laser oncology. T&W Holding A/S manages non-operating investments including listed and unlisted equities, private equity, real estate (including a co-investment in walls a/s), and infrastructure funds such as Copenhagen Infrastructure Partners. In April 2024 Lundbeckfonden acquired a minority share in T&W Medical's 51% WS Audiology stake, anchoring the operating business with long-duration strategic capital and a board seat. Group EBITDA before special items in FY2024/25 was DKK 3,234 million (16.8% margin), and total profit before tax was DKK 60 million, with DKK 249 million attributable to T&W Holding's investment returns.

Name

T&W Medical

Legal name

T&W Medical A/S

Website

https://twmedical.com

Company type

Private

Founded year

2019

Operating status

Operating

Short description

T&W Medical A/S is a family-owned Danish holding and investment company that owns and operates high-technology medtech and life-science businesses, anchored by a 51% majority stake in global hearing-aid manufacturer WS Audiology (Widex and Signia) and adjacent EEG, diagnostics, and biosensing holdings.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Audiology & Hearing Services (ENT-Affiliated) (HLAKAMAI)

Keywords

• Medtech holding company
• Hearing aid manufacturing
• Family office investments
• Life science ventures
• Medical device holdings

Headquarters

HQ city

Lynge

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. WS Audiology - Hearing Aids: Development, manufacturing and sale of hearing aids and related products through own sales companies and independent distributors globally.
2. UNEEG medical - EEG Monitoring: CE marked medical equipment for monitoring and diagnosing epilepsy through innovative EEG technology.
3. Cebreo Medical - EEG Monitoring Technology: Technology for discrete long-term monitoring based on EEG in combination with other sensors for epilepsy and neurological disorder treatment.
4. T&W Holding - Investment Returns: Investments in listed and unlisted companies, private equity, properties, infrastructure projects and alternative assets generating returns.
5. Seed and Venture Portfolio: Investments in medtech and life science companies at various stages of development with innovative research-based approaches.

Go-to-market motion1 record

Distribution channels1 record

Core offering

T&W Medical is a family-owned holding and investment company that owns and invests in high-tech companies within the medtech and life science sectors. Its principal holding is a 51% majority stake in WS Audiology (global hearing aid manufacturer with brands Widex and Signia). The company also holds UNEEG medical (EEG-based epilepsy monitoring), Cebreo Medical (long-term brain monitoring), T&W Engineering, and maintains a seed and venture portfolio of medtech/life science companies, plus other investments in properties and financial assets managed through T&W Holding.

Product overview

T&W Medical is a family-owned holding and investment company equally owned by the Tøpholm and Westermann families. The company operates a diversified medtech portfolio structured across three main areas: (1) Medtech holdings including WS Audiology (global hearing aid leader), UNEEG medical (EEG-based epilepsy monitoring), and Cebreo Medical (EEG long-term brain monitoring); (2) Seed and venture investments in innovative medtech/life science companies at various development stages including Cortrium (AI-based ECG/Holter), Eyenuk (AI eye screening), Biolinq (wearable glucose monitoring), O2matic (oxygen therapy), Human Bytes (AI clinical software), CelVivo (3D cell models), and Optheras (bladder cancer laser treatment); (3) Other investments in thematic capital (renewable energy), properties, and financial investments.

Differentiator

Problem solved

Functional benefit

Brands

• WS Audiology (WSA): Global hearing aid company under T&W Medical's majority ownership, operating brands including Widex and Signia
• UNEEG medical
• Cebreo Medical

Products and services

• WS Audiology (WSA) Global leader in hearing aids developing, manufacturing and selling hearing aids and related products under brands including Widex and Signia through own sales companies and independent distributors worldwide, serving millions of people with hearing loss across 130+ markets.
• UNEEG medical

Quantifiable outcome

• R&D investment of 1,387 mio. kr. (7% of revenue) in 2024/25
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Scale indicators16 records

Recent moves7 records

Expansion highlights5 records

Others

• Lundbeckfonden: Danish commercial foundation that acquired a minority share in T&W's WSA stake in April 2024. Structurally comparable as a long-term Danish healthcare capital provider with similar ownership orientation.
• EQT AB: Swedish private equity firm that co-owns 49% of WS Audiology through the 2019 Sivantos merger. Comparable as a co-controlling shareholder and capital partner in T&W Medical's core asset.
• Novo Holdings A/S: Holding company for the Novo Nordisk Foundation with diversified life sciences investments. Comparable as a Danish purpose-driven holding/investment entity anchored in healthcare, though much larger and broader in scope.

Direct peers

• Starkey Hearing Technologies: US-based privately held hearing aid manufacturer and one of the 'Big Five' global hearing aid brands. Competes head-to-head with WS Audiology across price tiers and channels, particularly strong in North America.
• GN Store Nord: Danish-based parent of GN Hearing (Resound, Beltone, Interton) and GN Audio (Jabra). Directly competitive in hearing aids with comparable Danish heritage, R&D intensity, and global distribution footprint.
• Sonova Holding AG: Swiss hearing aid company (Phonak, Unitron, Hansaton) with similar global scale and product portfolio. Directly competes with WS Audiology in the professionally-fitted hearing aid segment across all major markets.
• Demant A/S: Demant (parent of Oticon, Bernafon, Sonic, Philips Hearing) is a Danish hearing aid manufacturer of comparable size and global reach to WS Audiology. The most direct operating peer given the overlap in product categories, distribution model, and end-market.

Broad incumbents

• Cochlear Limited: Australian-listed implantable hearing solutions company (cochlear implants, bone conduction). Adjacent to WSA in hearing assistance but operates in the surgical implant segment rather than external hearing aids.
• Amplifon SpA: Italian-listed global hearing care retail and distribution company. Sells through partners like WS Audiology but also competing brands, making it a customer-distributor hybrid comparable in the hearing care value chain.

Emerging players

• Eargo, Inc. US-listed DTC/OTC hearing aid disruptor. Represents the emerging category of consumer-direct, lower-priced hearing aids that increasingly compete with WSA's professionally-fitted channel post the 2022 FDA OTC ruling.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about T&W Medical